Tuttle Capital Management LLC Acquires 272 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Tuttle Capital Management LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 34.7% during the fourth quarter, Holdings Channel reports. The fund owned 1,055 shares of the company’s stock after buying an additional 272 shares during the quarter. Tuttle Capital Management LLC’s holdings in HCA Healthcare were worth $317,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. FMR LLC raised its stake in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the period. Darsana Capital Partners LP grew its position in HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares during the period. Meritage Group LP bought a new position in shares of HCA Healthcare in the third quarter valued at $150,548,000. Holocene Advisors LP raised its holdings in shares of HCA Healthcare by 210.6% in the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after acquiring an additional 208,015 shares during the last quarter. Finally, Nordea Investment Management AB increased its holdings in HCA Healthcare by 29.7% during the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after purchasing an additional 193,075 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 1.7 %

HCA opened at $307.97 on Tuesday. The company has a market cap of $78.01 billion, a PE ratio of 13.83, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. The company has a 50 day moving average of $320.56 and a 200 day moving average of $353.55. HCA Healthcare, Inc. has a 12 month low of $276.50 and a 12 month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HCA. Barclays decreased their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Truist Financial lowered their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.